# The Effect of Choline Alfoscerate on Improvement of Cognitive Function in Elderly Patients With Diabetes

> **NCT03249259** · PHASE3 · COMPLETED · sponsor: **Seoul National University Bundang Hospital** · enrollment: 36 (actual)

## Conditions studied

- Diabetes Mellitus, Type 2

## Interventions

- **DRUG:** Choline alfoscerate
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT03249259
- **Lead sponsor:** Seoul National University Bundang Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-03-10
- **Primary completion:** 2019-06-30
- **Final completion:** 2019-09-30
- **Target enrollment:** 36 (ACTUAL)
- **Last updated:** 2019-10-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03249259

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03249259, "The Effect of Choline Alfoscerate on Improvement of Cognitive Function in Elderly Patients With Diabetes". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT03249259. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*